UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students - an interventional study

BMC medical education, 2024-02, Vol.24 (1), p.179-179, Article 179

2024

Volltextzugriff (PDF)

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

Oncotarget, 2015-03, Vol.6 (8), p.6105-6122

2015

Volltextzugriff (PDF)

In vitro model systems to study androgen receptor signaling in prostate cancer

Endocrine-related cancer, 2013-04, Vol.20 (2), p.R49-R64

2013

Volltextzugriff (PDF)

An NMR-based metabolic signature to identify clinically significant prostate cancer in patients undergoing biopsy

The journal of clinical endocrinology and metabolism, 2024-10

2024

Volltextzugriff (PDF)

Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer

Urologic oncology, 2020-11, Vol.38 (11), p.801-815

2020

Volltextzugriff (PDF)

Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells

The FEBS journal, 2016-06, Vol.283 (11), p.2181-2196

2016

Volltextzugriff (PDF)

Calcineurin inhibitor‐induced complement system activation via ERK1/2 signalling is inhibited by SOCS‐3 in human renal tubule cells

European journal of immunology, 2018-02, Vol.48 (2), p.330-343

2018

Volltextzugriff (PDF)

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo

Molecular endocrinology (Baltimore, Md.), 2015-12, Vol.29 (12), p.1694-1707

2015

Volltextzugriff (PDF)

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer

The Journal of steroid biochemistry and molecular biology, 2013-11, Vol.138, p.248-256

2013

Volltextzugriff (PDF)

Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells

Urology (Ridgewood, N.J.), 2011-06, Vol.77 (6), p.1508.e1-1508.e7

2011

Volltextzugriff (PDF)

SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner

Laboratory investigation, 2013-01, Vol.93 (1), p.123-134

2013

Volltextzugriff (PDF)

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (20), p.4640-4645

1998

Volltextzugriff (PDF)

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells

The Journal of steroid biochemistry and molecular biology, 2005-08, Vol.96 (3), p.251-258

2005

Volltextzugriff (PDF)

Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk-A Single Center Experience

Journal of clinical medicine, 2019-08, Vol.8 (8), p.1164

2019

Volltextzugriff (PDF)

Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer

Clinical prostate cancer, 2005-09, Vol.4 (2), p.124-129

2005

Volltextzugriff (PDF)

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α5β1?

BioMed research international, 2014, Vol.2014 (2014), p.1-12

2014

Volltextzugriff (PDF)

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines

Cancer research (Chicago, Ill.), 1999, Vol.59 (1), p.227-233

1999

Volltextzugriff (PDF)

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts

Future oncology (London, England), 2005-02, Vol.1 (1), p.93-101

2005

Volltextzugriff (PDF)

SP634THE COMPLEMENT SYSTEM AND MAPK SIGNALING IN CALCINEURIN-INHIBITOR INDUCED NEPHROTOXICITY

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i307-i307

2016

Volltextzugriff (PDF)

A Reliable System for the Culture of Human Prostatic Cells

In vitro cellular & developmental biology. Animal, 1997-11, Vol.33 (10), p.742-744

1997

Volltextzugriff (PDF)

Abstract 3: Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3-3

2015

Volltextzugriff (PDF)

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin [alpha]5[beta]1?

BioMed research international, 2014-01, Vol.2014

2014

Volltextzugriff (PDF)

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α 5 β 1 ?

BioMed research international, 2014, Vol.2014, p.1-12

2014

Volltextzugriff (PDF)

H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin [α.sub.5][β.sub.1]?

BioMed research international, 2014-01

2014

Volltextzugriff (PDF)

Selective culture conditions for different types of primary human bladder cells

World journal of urology, 2000-10, Vol.18 (5), p.371-375

2000

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaProstate Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students - an interventional study

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

In vitro model systems to study androgen receptor signaling in prostate cancer

An NMR-based metabolic signature to identify clinically significant prostate cancer in patients undergoing biopsy

Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer

Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells

Calcineurin inhibitor‐induced complement system activation via ERK1/2 signalling is inhibited by SOCS‐3 in human renal tubule cells

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer

Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells

SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells

Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk-A Single Center Experience

Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α5β1?

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts

SP634THE COMPLEMENT SYSTEM AND MAPK SIGNALING IN CALCINEURIN-INHIBITOR INDUCED NEPHROTOXICITY

A Reliable System for the Culture of Human Prostatic Cells

Abstract 3: Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin [alpha]5[beta]1?

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α 5 β 1 ?

H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin [α.sub.5][β.sub.1]?

Selective culture conditions for different types of primary human bladder cells

Aktive Filter

Suchergebnisse filtern